Your browser doesn't support javascript.
loading
Global heterogeneity assessed with 18F-FDG PET/CT. Relation with biological variables and prognosis in locally advanced breast cancer. / Medidas de heterogeneidad global y esfericidad con 18F-FDG PET/TC en el cáncer de mama: relación con la biología tumoral, valor predictivo y pronóstico.
Tello Galán, M J; García Vicente, A M; Pérez Beteta, J; Amo Salas, M; Jiménez Londoño, G A; Pena Pardo, F J; Soriano Castrejón, Á M; Pérez García, V M.
Afiliación
  • Tello Galán MJ; Servicio de Medicina Nuclear. Hospital General Universitario de Ciudad Real, España. Electronic address: mariajesustello1@gmail.com.
  • García Vicente AM; Servicio de Medicina Nuclear. Hospital General Universitario de Ciudad Real, España.
  • Pérez Beteta J; Instituto de Matemática Aplicada a la Ciencia y la Ingeniería. Universidad de Castilla La Mancha, Ciudad Real, España.
  • Amo Salas M; Departamento de Matemáticas. Universidad de Castilla La Mancha, Ciudad Real, España.
  • Jiménez Londoño GA; Servicio de Medicina Nuclear. Hospital General Universitario de Ciudad Real, España.
  • Pena Pardo FJ; Servicio de Medicina Nuclear. Hospital General Universitario de Ciudad Real, España.
  • Soriano Castrejón ÁM; Servicio de Medicina Nuclear. Hospital General Universitario de Ciudad Real, España.
  • Pérez García VM; Instituto de Matemática Aplicada a la Ciencia y la Ingeniería. Universidad de Castilla La Mancha, Ciudad Real, España.
Article en En, Es | MEDLINE | ID: mdl-31427247
ABSTRACT

AIM:

To analyze the relationship between measurements of global heterogeneity, obtained from 18F-FDG PET/CT, with biological variables, and their predictive and prognostic role in patients with locally advanced breast cancer (LABC). MATERIAL AND

METHODS:

68 patients from a multicenter and prospective study, with LABC and a baseline 18F-FDG PET/CT were included. Immunohistochemical profile [estrogen receptors (ER) and progesterone receptors (PR), expression of the HER-2 oncogene, Ki-67 proliferation index and tumor histological grade], response to neoadjuvant chemotherapy (NC), overall survival (OS) and disease-free survival (DFS) were obtained as clinical variables. Three-dimensional segmentation of the lesions, providing SUV, volumetric [metabolic tumor volume (MTV) and total lesion glycolysis (TLG)] and global heterogeneity variables [coefficient of variation (COV) and SUVmean/SUVmax ratio], as well as sphericity was performed. The correlation between the results obtained with the immunohistochemical profile, the response to NC and survival was also analyzed.

RESULTS:

Of the patients included, 62 received NC. Only 18 responded. 13 patients relapsed and 11 died during follow-up. ER negative tumors had a lower COV (p=0.018) as well as those with high Ki-67 (p=0.001) and high risk phenotype (p=0.033) compared to the rest. No PET variable showed association with the response to NC nor OS. There was an inverse relationship between sphericity with DFS (p=0.041), so, for every tenth that sphericity increases, the risk of recurrence decreases by 37%.

CONCLUSIONS:

Breast tumors in our LABC dataset behaved as homogeneous and spherical lesions. Larger volumes were associated with a lower sphericity. Global heterogeneity variables and sphericity do not seem to have a predictive role in response to NC nor in OS. More spherical tumors with less variation in gray intensity between voxels showed a lower risk of recurrence.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Radiofármacos / Fluorodesoxiglucosa F18 / Tomografía Computarizada por Tomografía de Emisión de Positrones Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En / Es Revista: Rev Esp Med Nucl Imagen Mol (Engl Ed) Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Radiofármacos / Fluorodesoxiglucosa F18 / Tomografía Computarizada por Tomografía de Emisión de Positrones Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En / Es Revista: Rev Esp Med Nucl Imagen Mol (Engl Ed) Año: 2019 Tipo del documento: Article